Sfoglia per AUTORE
ZHAO J
Collezione AOU Città della Salute di Torino
Items : 2
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study. in Translational lung cancer research / Transl Lung Cancer Res. 2023 Nov 30;12(11):2229-2244. doi: 10.21037/tlcr-23-577. Epub 2023 Oct 26.
2023
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Chen X; Zhang S; Gu Y; Tang Y; Mu X; Qin J; Yang X; He M; Liu Y; Zhong W; Gao J; Chen M; Zhao J; Gao X; Liu J; Zhang H; Shi Y; Zhao D; Shen F; Liu X; Zhang D; Pang L; Meng Q; Guo Y; Zhang Y; Li W; Xing P; Cheng Y; Xin T; et alii...
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. in Science translational medicine / Sci Transl Med. 2016 Jun 1;8(341):341ra76. doi: 10.1126/scitranslmed.aad3744.
2016
AOU Città della Salute di Torino
AOU Città della Salute di Torino
Scott RA; Freitag DF; Li L; Chu AY; Surendran P; Young R; Grarup N; Stancáková A; Chen Y; Varga TV; Yaghootkar H; Luan J; Zhao JH; Willems SM; Wessel J; Wang S; Maruthur N; Michailidou K; Pirie A; van der Lee SJ; Gillson C; Al Olama AA; Amouyel P; Arriola L; Arveiler D; Aviles-Olmos I; Balkau B; Barricarte A; Barroso I; et alii...